Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma 100mg Tablets Taj Pharma : Uses, Side Effects, Interactions, Pictures, Warnings, Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma Dosage & Rx Info | Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma Uses, Side Effects, Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma : Indications, Side Effects, Warnings, Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma - Drug Information - Taj Pharma, Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma dose Taj pharmaceuticals Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma interactions, Taj Pharmaceutical Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma contraindications, Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma price, Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma Taj Pharma Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma 100mg Tablets PIL- Taj Pharma Stay connected to all updated on Betahistine dihydrochloride Tablets 8mg/ 16mg/ 24mg Taj Pharma Taj Pharmaceuticals Taj pharmaceuticals Hyderabad. Patient Information Leaflets, PIL.
of which may include vertigo, tinnitus, hearing loss and nausea
BETAHISTINE DIHYDROCHLORIDE TABLETS 8MG/ 16MG/ 24MG TAJ PHARMA
Betahistine Dihydrochloride Tablets 8mg Taj Pharma Betahistine Dihydrochloride Tablets 16mg Taj Pharma Betahistine Dihydrochloride Tablets 24mg Taj Pharma 2. QUALITATIVE AND QUANTITATIVE COMPOSITION a) Each uncoated tablet contains:
Excipients
8mg q.s.
b) Each uncoated tablet contains: Betahistine Dihydrochloride Excipients
16mg q.s.
c) Each uncoated tablet contains: Betahistine Dihydrochloride Excipients
Adults: Initial oral treatment is 8 to 8mg/16mg/24mg three times daily, taken preferably with meals.
1. NAME OF THE MEDICINAL PRODUCT
Betahistine Dihydrochloride
4.2 Posology and method of administration Dosage
24mg q.s.
For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet. 4. CLINICAL PARTICULARS 4.1 Therapeutic indications Betahistine Dihydrochloride is indicated for treatment of MÊnière's syndrome, symptoms
Maintenance doses are generally in the range 24 - 48 mg daily. Daily dose should not exceed 48 mg. Dosage can be adjusted to suit individual patient needs. Sometimes improvement could be observed only after a couple of weeks of treatment. Renal impairment There are no specific clinical trials available in this patient group, but according to postmarketing experience no dose adjustment appears to be necessary. Hepatic impairment There are no specific clinical trials available in this patient group, but according to postmarketing experience no dose adjustment appears to be necessary. Elderly population Although there are limited data from clinical studies in this patient group, extensive post marketing experience suggests that no dose adjustment is necessary in this population. Paediatric population: Betahistine Dihydrochloride tablets are not recommended for use in children and adolescents below age 18 due to lack of data on safety and efficacy. Method of administration Take the tablets preferably with meals or after meals with a glass of water. 4.3 Contraindications